Description:
Pacritinib is an orally bioavailable and ATP-competitive inhibitor of JAK2 (IC50 = 23 nM), and also inhibits FLT3 (IC50 = 22 nM). It suppresses proliferation in cells carrying the JAK2V617F mutation.
- Molecular Weight:472.589
- Boiling Point:711.4±70.0 °C at 760 mmHg
- Purity:>98%
Molecular Formula:
C28H32N4O3
Canonical SMILES:
C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC=CC(=C4)C5=NC(=NC=C5)NC(=C3)C=C2
InChI:
InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
InChIKey:
HWXVIOGONBBTBY-ONEGZZNKSA-N
Application:
For research used only
Synonyms:
SB1518; SB-1518 Weitere Informationen finden Sie
hier